Treatment Algorithm A
RP1706
Approved mab active
Quick answer
Treatment Algorithm A for Colitis, Ulcerative is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Colitis, Ulcerative
- Phase
- Approved
- Modality
- mab
- Status
- active